Center for Cannabis, Cannabinoids, and Addiction

Welcome to C3A

Welcome to the Center for Cannabis, Cannabinoids, and Addiction (C3A) at Indiana University, Bloomington! This grant is awarded to Dr. Ken Mackie in the Department of Psychological and Brain Sciences

This Center is supported by the National Institute on Drug Abuse of the National Institutes of Health, and with additional contributions and support from the Office of the Vice President for Research,  College of Arts + Sciences, Department of Psychological and Brain Science, and the Linda and Jack Gill Center for Biomolecular Science

Overview

About Us

Indiana University, Bloomington's Center for Cannabis, Cannabinoids, and Addiction (C3A) was established to support drug abuse researchers across the central Midwest and around the nation. The Center consists of research cores to support the work of these researchers as they measure lipid biomarkers associated with addiction and apply cutting-edge optical imaging to learn how drug addiction affects brain anatomy and function. The Center also has a strong educational component to bring more researchers into drug addiction research, particularly drawing from populations not well-represented in the field, and to train scientists in the cutting-edge technologies used in the Center.

Our Mission

The mission of the Indiana University, Bloomington's Center for Cannabis, Cannabinoids, and Addiction (C3A) is to connect investigators studying high impact problems in substance use disorder and addiction research with the imaging and mass spectrometric technology that will assist them in efficiently and creatively addressing these problems. Further, the C3A serves the substance use disorder and addiction research community by offering educational opportunities and training aimed to engage undergraduate students and investigators new to or traditionally underrepresented in cannabis, cannabinoids, and/or addiction research.

 

Upcoming Events

There are no events at this time.

Acknowledgements

Disclaimer

Research and content found in this publication is supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Number P30DA056410. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.